Almotriptan: an effective and well-tolerated treatment for migraine pain.

Abstract

The clinical data of almotriptan, the new selective 5-HT(1B/1D) agonist developed for the symptomatic treatment of migraine, are reviewed here. The pharmacokinetic performance of almotriptan is compared with that of other currently available triptans. The dose exhibiting the best efficacy/tolerability ratio of almotriptan is 12.5 mg. Efficacy of this… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.